ETF Holdings Breakdown of DYN
| Stock Name | Dyne Therapeutics Inc |
| Ticker | DYN(USD) NASDAQ |
| TYPE | Common Stock |
| Country | USA |
| ISIN | US26818M1080 |
| Ticker | DYN(EUR) F |
DYN institutional holdings
The adjusted close for DYN on 2025-12-03 was 20.09
The following institutional investment holdings of DYN have been identified
| Date | ETF ISIN/Name | Num Shares | Book value | Derived Price per Share | Comment |
| 2025-12-03 | IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc)) | 562 | USD 11,291  0.5% | 20.09  | |
| 2025-12-03 | IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc) | 18,215  -1.7% | USD 365,939 -1.2% | 20.09 | |
| 2025-12-03 | IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) | 100,429 | USD 2,017,619 0.5% | 20.09 | |
| 2025-12-03 | IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc)) | 78,495 | USD 1,576,965 0.5% | 20.09 | |
| 2025-12-03 | IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) | 100,429 | USD 2,017,619 0.5% | 20.09 | |
| Total = | 298,130 | USD 5,989,433 |
Book value of shares is calculated on the adjusted close price of each day (row).News associated with DYN
- Wednesday 7/16 Insider Buying Report: DYN, HELE
- Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned dollars to make a purchase, is that they expect to make money. Today - 2025-07-16 12:12:03
- After Hours Most Active for Jun 16, 2025 : HPP, T, DYN, PLTR, KVUE, HPE, NVDA, GME, AAPL, GRAB, DWSN, WFC
- The NASDAQ 100 After Hours Indicator is down -15.67 to 21,921.9. The total After hours volume is currently 122,781,121 shares traded.The following are the most active stocks for the after hours session: Hudson Pacific Properties, Inc. (HPP) is -0.001 at $2.75, with 10,069,684 sh - 2025-06-16 17:29:55
- Dyne Therapeutics, Inc. Q4 Loss Beats Estimates
- (RTTNews) - Dyne Therapeutics, Inc. (DYN) revealed Loss for fourth quarter that beat the Street estimates. - 2025-02-27 10:35:54
Back to Listing
Disclaimer
All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.
Copyright Market Footprint Ltd. Privacy Policy